miR-191 is reported to regulate cancer progression and chemosensitivity in ovarian cancer by modulating the level of MDM4 through binding with an illegitimate site (rs4245739) within the 3′ UTR (Wynendaele et al., 2010). This evidence concerns the gene MDM4 and cancer.